Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Johnson & Johnson
(NY:
JNJ
)
221.32
-1.19 (-0.53%)
Official Closing Price
Updated: 7:00 PM EDT, May 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Johnson & Johnson
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Johnson & Johnson to Participate in the Bank of America 2026 Healthcare Conference
April 15, 2026
From
Johnson & Johnson
Via
Business Wire
J&J Shatters Estimates as Oncology and MedTech Power 2026 Outlook Higher
April 15, 2026
Johnson & Johnson (NYSE: JNJ) delivered a robust first-quarter 2026 earnings report on April 14, 2026, handily beating Wall Street expectations and signaling a successful navigation of the long-feared...
Via
MarketMinute
Topics
Economy
Intellectual Property
These Analysts Boost Their Forecasts On Johnson & Johnson Following Strong Q1 Results
↗
April 15, 2026
Johnson & Johnson (NYSE:JNJ) reports upbeat earnings for Q1, with higher sales and raised fiscal 2026 guidance. Some analysts raise price targets.
Via
Benzinga
Johnson & Johnson Posts Solid Q1 To Kickstart 'Year Of Accelerating Growth,' Says Bullish Analyst
↗
April 15, 2026
Johnson & Johnson reports strong Q1, beating expectations and setting the stage for future growth. Analysts maintain Buy rating.
Via
Benzinga
Consolidation Fever: Boston Scientific’s $14.9 Billion Bet on Penumbra Signals New Era in MedTech M&A
April 15, 2026
In a move that has sent shockwaves through the healthcare sector, Boston Scientific Corporation (NYSE: BSX) announced its definitive agreement to acquire Penumbra, Inc. (NYSE: PEN) for approximately...
Via
MarketMinute
Topics
Economy
Transcript: Johnson & Johnson Q1 2026 Earnings Conference Call
↗
April 15, 2026
Via
Benzinga
Oil Drops, Dimon Warns, and the Record Is Within Reach
↗
April 15, 2026
Within 0.2% of its January all-time high. That's where the S&P 500 closed on Tuesday, not quite there yet, but close enough that the question investors are asking has quietly shifted from "when does...
Via
Chartmill
Topics
Artificial Intelligence
Economy
Government
MedTech Surge and Oncology Resilience Drive Johnson & Johnson to Q1 Earnings Beat
April 14, 2026
In a resounding display of corporate resilience, Johnson & Johnson (NYSE:JNJ) reported first-quarter 2026 financial results that surpassed Wall Street expectations, signaling a successful navigation of...
Via
MarketMinute
Topics
Bankruptcy
Earnings
Economy
What Makes a Healthcare Stock Worth Holding Through a Recession?
↗
April 14, 2026
Not all healthcare stocks are defensive in a downturn. Here's what to consider.
Via
The Motley Fool
Topics
Economy
Johnson & Johnson: A 20% Gain Looks Easy After Q1 Earnings Results
↗
April 14, 2026
Via
MarketBeat
Johnson & Johnson Q1 2026 Earnings Call Transcript
↗
April 14, 2026
Johnson & Johnson (NASDAQ: JNJ) reported first-quarter financial results on Tuesday. The transcript from the company's first-quarter earnings call has been provided below.
Via
Benzinga
Topics
Earnings
Johnson & Johnson Shatters Expectations in Q1 2026, Raising Full-Year Outlook as Healthcare Giant Pushes Toward $100 Billion Milestone
April 14, 2026
NEW BRUNSWICK, N.J. — In a powerful display of resilience and strategic execution, Johnson & Johnson (NYSE: JNJ) reported first-quarter 2026 financial results that exceeded Wall Street estimates across...
Via
MarketMinute
Topics
Economy
Intellectual Property
Johnson & Johnson Q1 Performance: Cancer Drug Revenue Grows, Free Cash Flow Falls, Hikes Dividend
↗
April 14, 2026
Johnson & Johnson Q1 pharma growth offsets immunology decline; company raises guidance and extends dividend streak.
Via
Benzinga
The New J&J: A 2026 Deep Dive into the Global Healthcare Titan
April 14, 2026
As of April 14, 2026, Johnson & Johnson (NYSE: JNJ) stands as a radically different entity than it was only three years ago. Following the successful spin-off of its consumer health division, Kenvue,...
Via
Finterra
Topics
Artificial Intelligence
Death
Economy
Dow Jones' J&J Slips Despite Beating First-Quarter Calls, Hiking Guidance
↗
April 14, 2026
Johnson & Johnson stock fell early Tuesday despite better-than-expected first-quarter sales and earnings, and a guidance hike.
Via
Investor's Business Daily
Topics
Stocks
Johnson & Johnson Announces 64th Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 3.1%
April 14, 2026
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson reports Q1 2026 results, raises 2026 outlook
April 14, 2026
From
Johnson & Johnson
Via
Business Wire
Dow Jones Stocks In Spotlight: JPMorgan, Johnson & Johnson Among This Week's Earnings Reports
↗
April 13, 2026
Four of the 30 Dow Jones Industrial Average stocks report this week. Here's a look at the companies and what the key figures to watch are.
Via
Benzinga
Topics
Stocks
Is This Dividend King With a 63-Year Dividend Streak A Buy Before April 14?
April 13, 2026
This Dividend King offers a rare mix of safety and upside heading into earnings.
Via
Barchart.com
Which Dividend Pharma Stock Should a Value Investor Choose Today?
↗
April 12, 2026
Bristol Myers Squibb looks like a value buy, so long as its pipeline remains strong.
Via
The Motley Fool
Topics
Intellectual Property
Nvidia Built an AI Chip Empire. But It's This Other Creation That Makes the Stock a Screaming Buy Today.
↗
April 12, 2026
The future looks bright for this AI star.
Via
The Motley Fool
Topics
Artificial Intelligence
History Says the Best Time to Buy Stocks May Be Imminent
↗
April 12, 2026
The best time to buy stocks may be closer than you think -- and history has the receipts.
Via
The Motley Fool
Topics
Government
Stocks
World Trade
Better Buy Right Now: Johnson & Johnson Vs. Pfizer
↗
April 12, 2026
The choice is based on more than just the dividend payout.
Via
The Motley Fool
Topics
Artificial Intelligence
Smooth Investing When the Ride Is Bumpy
↗
April 11, 2026
Diversification is a winning strategy for the long term, especially in a volatile market.
Via
The Motley Fool
The $100 Billion Pivot: Why Johnson & Johnson Is My Top Dividend King to Buy in 2026
↗
April 11, 2026
This stock might help you sleep more easily at night.
Via
The Motley Fool
Topics
Economy
Intellectual Property
Lawsuit
4 Stocks That Can Fund Decades of Passive Income -- Buy Them While They're Down
↗
April 11, 2026
These defensive consumer stocks are flashing buy signals while the market chases AI hype.
Via
The Motley Fool
Topics
Artificial Intelligence
Stocks Rallied After President Donald Trump's Ceasefire in Iran. Here's How to Invest Now.
↗
April 11, 2026
Moves made now could position your portfolio for success over time.
Via
The Motley Fool
Topics
Government
Stocks
Johnson & Johnson Showcases New Clinical Data for TECNIS PureSee IOL at ASCRS 2026 Demonstrating Excellent Contrast Sensitivity and Extended Range of Vision
April 10, 2026
From
Johnson & Johnson
Via
Business Wire
Could Buying This Dividend Pharma Stock Today Set You Up for Life?
↗
April 09, 2026
This Dividend King drug maker's dividend yield is roughly twice that of the S&P 500 index.
Via
The Motley Fool
Topics
Stocks
Robotics and AI in Drug Manufacturing: May Unlock Efficiency Gains, Long-Term Value
April 09, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
